Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue Dysplasia

Undifferentiated connective tissue dysplasia is one of the most common diseases of nowadays, which does not fit into the group of hereditary syndromes. This condition is diagnosed in 20–50% of the population at any age. The study aimed to correct the facial soft tissues of patients with undifferenti...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Shirshakova, Elena Morozova, Daria Sokolova, Svetlana Pervykh, Lyailya Kayumova
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/6673058
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524577766735872
author Maria Shirshakova
Elena Morozova
Daria Sokolova
Svetlana Pervykh
Lyailya Kayumova
author_facet Maria Shirshakova
Elena Morozova
Daria Sokolova
Svetlana Pervykh
Lyailya Kayumova
author_sort Maria Shirshakova
collection DOAJ
description Undifferentiated connective tissue dysplasia is one of the most common diseases of nowadays, which does not fit into the group of hereditary syndromes. This condition is diagnosed in 20–50% of the population at any age. The study aimed to correct the facial soft tissues of patients with undifferentiated connective tissue dysplasia through the cosmetic procedure of calcium hydroxylapatite injection. In 2018, a 36-year-old patient addressed the beauty salon with signs of undifferentiated connective tissue dysplasia, such as severe asymmetry of the face, infraorbital and nasolabial sulci, and thin and easily folding skin. Signs were observed from the age of 22, i.e., for 14 years. The therapy was performed using special features of the correction of facial soft tissue changes in patients with connective tissue dysplasia (CTD) using calcium hydroxylapatite-based products (Radiesse®, Merz North America, Inc., USA). Particular attention is given to the need for early correction to prevent premature skin aging related to this condition. After 14 days, a significant improvement of the patient’s skin condition was noted after the passing of two procedures. Her condition was estimated as consistent with T1-2P0G0A1Zh1 P1M1K1 and corresponded to grade I age-related changes in the superficial soft tissues. The performed treatment showed high efficacy in case of mild connective tissue dysplasia diagnosis. The results showed that when collecting information from anamnesis, the diagnostic criteria for dysplasia should be considered. If the criteria are met, the cosmetological correction with collagen stimulators becomes possible.
format Article
id doaj-art-d90dff350a3340e1b7d8b8fefb77e63a
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-d90dff350a3340e1b7d8b8fefb77e63a2025-02-03T05:52:56ZengWileyDermatology Research and Practice1687-61051687-61132021-01-01202110.1155/2021/66730586673058Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue DysplasiaMaria Shirshakova0Elena Morozova1Daria Sokolova2Svetlana Pervykh3Lyailya Kayumova4Aesthetic Clinics of Maria Shirshakova, Moscow, RussiaI. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaClinic: Center of Medical Practice, Moscow, RussiaClinic of Evidence-Based Medicine DocMed, Moscow, RussiaI. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaUndifferentiated connective tissue dysplasia is one of the most common diseases of nowadays, which does not fit into the group of hereditary syndromes. This condition is diagnosed in 20–50% of the population at any age. The study aimed to correct the facial soft tissues of patients with undifferentiated connective tissue dysplasia through the cosmetic procedure of calcium hydroxylapatite injection. In 2018, a 36-year-old patient addressed the beauty salon with signs of undifferentiated connective tissue dysplasia, such as severe asymmetry of the face, infraorbital and nasolabial sulci, and thin and easily folding skin. Signs were observed from the age of 22, i.e., for 14 years. The therapy was performed using special features of the correction of facial soft tissue changes in patients with connective tissue dysplasia (CTD) using calcium hydroxylapatite-based products (Radiesse®, Merz North America, Inc., USA). Particular attention is given to the need for early correction to prevent premature skin aging related to this condition. After 14 days, a significant improvement of the patient’s skin condition was noted after the passing of two procedures. Her condition was estimated as consistent with T1-2P0G0A1Zh1 P1M1K1 and corresponded to grade I age-related changes in the superficial soft tissues. The performed treatment showed high efficacy in case of mild connective tissue dysplasia diagnosis. The results showed that when collecting information from anamnesis, the diagnostic criteria for dysplasia should be considered. If the criteria are met, the cosmetological correction with collagen stimulators becomes possible.http://dx.doi.org/10.1155/2021/6673058
spellingShingle Maria Shirshakova
Elena Morozova
Daria Sokolova
Svetlana Pervykh
Lyailya Kayumova
Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue Dysplasia
Dermatology Research and Practice
title Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue Dysplasia
title_full Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue Dysplasia
title_fullStr Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue Dysplasia
title_full_unstemmed Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue Dysplasia
title_short Cosmetic Syndrome Correction with Calcium Hydroxylapatite-Based Filler in Patients with Connective Tissue Dysplasia
title_sort cosmetic syndrome correction with calcium hydroxylapatite based filler in patients with connective tissue dysplasia
url http://dx.doi.org/10.1155/2021/6673058
work_keys_str_mv AT mariashirshakova cosmeticsyndromecorrectionwithcalciumhydroxylapatitebasedfillerinpatientswithconnectivetissuedysplasia
AT elenamorozova cosmeticsyndromecorrectionwithcalciumhydroxylapatitebasedfillerinpatientswithconnectivetissuedysplasia
AT dariasokolova cosmeticsyndromecorrectionwithcalciumhydroxylapatitebasedfillerinpatientswithconnectivetissuedysplasia
AT svetlanapervykh cosmeticsyndromecorrectionwithcalciumhydroxylapatitebasedfillerinpatientswithconnectivetissuedysplasia
AT lyailyakayumova cosmeticsyndromecorrectionwithcalciumhydroxylapatitebasedfillerinpatientswithconnectivetissuedysplasia